Treatment of cystic fibrosis related bone disease
The advent of highly effective CFTR modulator therapies has slowed the progression of pulmonary complications in people with cystic fibrosis. There is increased interest in cystic fibrosis bone disease (CFBD) due to the increasing longevity of people with cystic fibrosis. CFBD is a complex and multi...
Main Authors: | Jagdeesh Ullal, Katherine Kutney, Kristen M. Williams, David R. Weber |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Journal of Clinical & Translational Endocrinology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214623721000430 |
Similar Items
-
Cystic fibrosis related liver disease and endocrine considerations
by: Jordan S. Sherwood, et al.
Published: (2022-03-01) -
Bone mineral density, pulmonary function, chronological age, and age at diagnosis in children and adolescents with cystic fibrosis
by: Márcio V.F. Donadio, et al.
Published: (2013-03-01) -
An update on methods for assessing bone quality and health in Cystic fibrosis
by: Kristen M. Williams, et al.
Published: (2022-03-01) -
Findings from a feasibility study of estradiol for hypogonadal women with cystic fibrosis-related bone disease
by: Malinda Wu, et al.
Published: (2021-08-01) -
Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation
by: Óscar Fonseca, et al.
Published: (2023-02-01)